- When clinical AI gets realWe’re heading toward a future in which certain parts of medical care are delivered without any humans involved. Cadence, which raised a $100 million Series C last week, is betting that it can mak…Endpoints · 22d ago↗ source
- Scribe Therapeutics files for IPO in test of appetite for early-stage biotechsScribe Therapeutics filed for a Nasdaq IPO late Thursday. The move marks a pivotal moment for the biotech and the gene editing field. The novel CRISPR enzyme developer was created nine ...Endpoints · 23d ago↗ source
- Sandoz launches direct-to-consumer platform with growth disorder drugSandoz unveiled a direct-to-consumer platform, starting off with a single medication for now as the generic drugmaker adopts a system that several brand-name manufacturers are using to cut out-of-p…